Noro-Moseley Partners
Overview
Noro-Moseley Partners is an Atlanta-based early growth equity firm that focuses on investing in rapidly scaling B2B software and healthcare companies across the US and Canada . Since 1983, NMP has built deep domain expertise and curated a valuable network within the B2B software and healthcare markets . NMP seeks to invest initially $2 million to $7 million in early-stage companies and up to $10 million in growth companies . NMP has the ability to provide follow-on financings of up to $20 million in any single transaction .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| DigiLens | Nov 2002 | Series E | Co-investor |
| Axuall | May 2023 | Series B | Lead |
| Voxie | Feb 2022 | Series A Extension | Co-investor |
| Malbek | Sep 2021 | Series A | Lead |
| AvoMD | Mar 2026 | Series A | Lead |
For institutional investors. Book with your work email.
Key People
Alan Taetle
General Partner
Allen Moseley
Managing General Partner
Vasant Kamath
General Partner
William Hudson
Chief Financial Officer & Administrative Partner
Ryan Collins
Principal
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Noro-Moseley Partners based?
Noro-Moseley Partners is headquartered in Atlanta, Georgia, United States.
When was Noro-Moseley Partners founded?
Noro-Moseley Partners was founded in 1983.
How many portfolio companies does Noro-Moseley Partners have?
Noro-Moseley Partners has 29 portfolio companies in Caplight's dataset.
What are some companies in Noro-Moseley Partners's portfolio?
Portfolio companies visible on Caplight include DigiLens, Axuall, Voxie, Malbek, AvoMD.
What was Noro-Moseley Partners's most recent investment shown here?
Noro-Moseley Partners's most recent investment in this portfolio sample was in AvoMD in 2026.
What sectors does Noro-Moseley Partners focus on?
Noro-Moseley Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Mobility, Transportation & Logistics, Healthcare & Life Sciences, Cybersecurity, Cybersecurity, Enterprise Software, Healthcare & Life Sciences, Consumer & Commerce, Enterprise Software, Healthcare & Life Sciences, Media, Entertainment & Gaming, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, Frontier & Industrial Tech, Enterprise Software, Healthcare & Life Sciences, Enterprise Software, Healthcare & Life Sciences, Enterprise Software, Frontier & Industrial Tech, Enterprise Software, Healthcare & Life Sciences, Cybersecurity, Enterprise Software, Mobility, Transportation & Logistics, AI, Data & Cloud Infrastructure, Enterprise Software, Enterprise Software, AI, Data & Cloud Infrastructure, FinTech, Mobility, Transportation & Logistics, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software, Healthcare & Life Sciences, Consumer & Commerce, AI, Data & Cloud Infrastructure, Enterprise Software, Enterprise Software, Enterprise Software, Enterprise Software, Enterprise Software, Consumer & Commerce, AI, Data & Cloud Infrastructure, Enterprise Software, Enterprise Software, Enterprise Software.
What company stages does Noro-Moseley Partners focus on?
Noro-Moseley Partners typically invests at the Mid stage.
What is Noro-Moseley Partners's AUM?
Noro-Moseley Partners's assets under management are estimated between $100.0M and $250.0M.